AHF criticizes HHS Secretary announcement on 'expanded' AIDS funds

AIDS Healthcare Foundation (AHF) today criticized an announcement by Health and Human services (HHS) Secretary Kathleen Sebelius yesterday regarding so-called "expanded" funding for cash-strapped state AIDS Drug Assistance Programs (ADAPs). During a press briefing about AIDS funding—designed to coincide with the 30th anniversary of the discovery of the disease—Secretary Sebelius announced that $50 million will be made available to assist states that currently have patients on waiting lists. However, these are monies already appropriated by Congress for this very purpose. It is in fact not new HHS monies. In addition, by simply giving funds to states that already have waiting lists, new waiting list states are being created.

As of June 2nd, there are 8,111 individuals on waiting lists to receive lifesaving AIDS medications in thirteen states. Hundreds of patients in need are being added to the waiting list each week. In addition, thousands more Americans living with HIV/AIDS have been dropped from the program or made ineligible to receive medications through ADAP due to stricter eligibility requirements.

"It is crucial that the Obama administration address rapidly escalating waiting lists for the nation's network of hard-hit AIDS Drug Assistance Programs; however, by using all the new money for waiting list states, the Obama administration and HHS are simply creating new waiting list states and penalizing those states that have increased their own share of the funding," said Michael Weinstein, President of the AIDS Healthcare Foundation (AHF) Foundation in a statement from Florida, the state with the largest ADAP waiting list. "It's called a shell game, or three card Monty, and states that have already stepped up to the plate on their own to assist some of their most vulnerable citizens should not be punished by the Feds for having done the right thing."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Semaglutide improves heart health and reduces weight in obese patients, but with side effects